Eledon Pharmaceuticals, Inc. (ELDN) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Eledon Pharmaceuticals, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -2.71x | -5.53x | -0.38x | -0.37x | -1.89x | -0.98x |
| P/B Ratio | 1.52x | 1.69x | 6.15x | 0.39x | 0.40x | 0.12x |
| P/S Ratio | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x |
| Profitability | ||||||
| Gross Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Operating Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| EBITDA Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Liquidity | ||||||
| Current Ratio | 7.40x | 12.42x | 14.41x | 9.19x | 20.07x | 46.57x |
| Quick Ratio | 7.40x | 12.42x | 14.41x | 9.19x | 20.07x | 46.57x |
| Leverage | ||||||
| Debt/Equity | 0.01x | 0.01x | 0.05x | 0.01x | 0.00x | 0.00x |
YoY = year-over-year change. Source: FMP..